Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × Sorafenib × Clear all

NCT00199160 2015-05-20

Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Phase 2 Completed

Head and Neck Neoplasms